Serum Ionized Calcium A Predictor of Therapeutic Response To Slow Calcium Channel Blockade in Essential Hypertension

Abstract

In 20 patients with mild to moderate essential hypertension, serum ionized calcium was determined before and after four weeks of treatment with 240 mg verapamil sustained release bid. Pretreatment systolic blood pressure was inversely correlated to serum ionized calcium (r = — 0.44, p = 0.05). Mean blood pressure was significantly (p < 0.001) reduced (from 161/100 to 145/88 mm Hg), but mean serum ionized calcium did not change during treatment (from 1.23 to 1.24 mmol/L).

A significant inverse correlation (r = -0.56, p = 0.01) was found between pretreatment serum ionized calcium and reduction in systolic blood pressure during verapamil treatment. Thus serum ionized calcium in untreated essential hypertensive patients may predict the blood pressure response to the slow calcium channel blocker verapamil.

Get full access to this article

View all access options for this article.

References

Bolton TB : Mechanisms of action of transmitters and other substances on smooth muscle . Physiol Rev 59:606-718, 1979.

Fleckenstein A. : Calcium antagonism in heart and smooth muscle. Experimental facts and therapeutic prospects. New York: John Wiley & Sons, 1983, pp. 209-212.

Swales JD : Ion transport in hypertension. Biosci Rep 2:967-990, 1982.

Postnov YV , Orlov SN : Cell membrane alteration as a source of primary hypertension. J Hypertension 2:1-6, 1984.

Robinson BF : Altered calcium handling as a cause of primary hypertension. J Hypertension 2:453-460, 1984.

McCarron DA : Low serum concentrations of ionized calcium in patients with hypertension . N Engl J Med 307:226-228, 1982.

Resnick LM , Laragh JH , Sealey JE , Alderman MH : Divalent cations in essential hypertension. Relations between serum ionized calcium magnesium, and plasma renin activity. N Engl J Med 309:888-891, 1983.

Resnick LM , Nicholson JP , Laragh JH : Calcium metabolism and renin-aldosterone system in essential hypertension . J Cardiovasc Pharmacol 7(Suppl 6):S187-S193, 1985.

Fogh-Andersen N. : Ionized calcium analyzer with a built-in pH correction. Clin Chem 27:1264-1267, 1981 .

10.

Winer BJ : Statistical Principles in Experimental Design, 2nd ed. New York: McGraw-Hill, 1971.

11.

Lewis Grj , Morley KD , Lewis BM , Bones PJ : The treatment of hypertension with verapamil. N Z Med J 87:351-354, 1978.

12.

Midtbø K. , Hals O. , van der Meer J. , Storstein L. , Lauve O. : Instant and sustained release verapamil in the treatment of essential hypertension . Am J Cardiol 57:59D-63D, 1986.

13.

Singer Drj , Markandu ND , Cappuccio FP , Beynon GW , et al: Does oral calcium lower blood pressure: A double-blind study . J Hypertension 3:661, 1985.

14.

Fray Jcs : Stimulus-secretion coupling of renin: Role of haemodynamic and other factors . Circ Res 47:485-492, 1980.

15.

Braunwald E. : Mechanism of action of calcium-channel-blocking agents. N Engl J Med 307:1618-1627, 1982 .

16.

Zidek W. , Losse H. , Vetter H. : Effect of nifedipine on blood pressure and on intracellular calcium in arterial hypertension. J Cardiovasc Pharmacol 4:S303-S305, 1982.

17.

Ericsson F. : Effect of nifedipine on cellular electrolytes in fourteen patients with untreated primary hypertension. Acta Med Scand 218:69-72, 1985.

18.

Erne P. , Bolli P. , Burgisser E. , Bühler FR : Correlation of platelet calcium and blood pressure: Effect of hypertensive therapy. N Engl J Med 310:1084-1088, 1984 .

19.

Baudouin M. , Meyer P. , Fermandjian S. , Morgat J-L. : Calcium release induced by interaction of angiotensin with its receptors in smooth muscle cell microsomes. Nature 235:336-338, 1972.